Introduced
by
To impose a new coverage mandate that would require insurance companies to include coverage for orally administered chemotherapy in all their health insurance policies that provide for cancer chemotherapy treatments, without requiring any dollar limit, deductible or co-pay for these that does not apply to other treatments. Also, to prohibit an insurer from requiring a copayment greater than $100 for a 30 day supply of the pills.
Referred to the Committee on Insurance
Reported without amendment
With the recommendation that the substitute (S-1) be adopted and that the bill then pass.
Passed in the Senate 36 to 1 (details)
Referred to the Committee on Insurance
Reported without amendment
With the recommendation that the bill be referred to the Committee on Health Policy.
Referred to the Committee on Health Policy
